Clinical Trial Update: Lupus Cohort--Thrombotic Events and Coronary Artery Disease

View source ↗

Summary

This update summarizes outcomes from a lupus cohort in a completed trial, focusing on thrombotic events and coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Coronary Artery Disease
• Systemic Lupus Erythematosus
• Thrombosis

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Coronary Disease | Status: COMPLETED